These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 25965956)
1. A temperature-monitoring vaginal ring for measuring adherence. Boyd P; Desjardins D; Kumar S; Fetherston SM; Le-Grand R; Dereuddre-Bosquet N; Helgadóttir B; Bjarnason Á; Narasimhan M; Malcolm RK PLoS One; 2015; 10(5):e0125682. PubMed ID: 25965956 [TBL] [Abstract][Full Text] [Related]
2. Pre-clinical development of a combination microbicide vaginal ring containing dapivirine and darunavir. Murphy DJ; Desjardins D; Dereuddre-Bosquet N; Brochard P; Perrot L; Pruvost A; Le Grand R; Lagatie O; Vanhooren L; Feyaerts M; van Roey J; Malcolm RK J Antimicrob Chemother; 2014 Sep; 69(9):2477-88. PubMed ID: 24862093 [TBL] [Abstract][Full Text] [Related]
3. Safety of a silicone elastomer vaginal ring as potential microbicide delivery method in African women: A Phase 1 randomized trial. Nel A; Martins J; Bekker LG; Ramjee G; Masenga G; Rees H; van Niekerk N PLoS One; 2018; 13(5):e0196904. PubMed ID: 29813074 [TBL] [Abstract][Full Text] [Related]
4. Packing Polymorphism of Dapivirine and Its Impact on the Performance of a Dapivirine-Releasing Silicone Elastomer Vaginal Ring. McCoy CF; Murphy DJ; Boyd P; Derrick T; Spence P; Devlin B; Malcolm RK J Pharm Sci; 2017 Aug; 106(8):2015-2025. PubMed ID: 28456732 [TBL] [Abstract][Full Text] [Related]
5. Impact of ring size and drug loading on the pharmacokinetics of a combination dapivirine-darunavir vaginal ring in cynomolgus macaques. Murphy DJ; Desjardins D; Boyd P; Dereuddre-Bosquet N; Stimmer L; Caldwell A; Le Grand R; Kelly C; van Roey J; Malcolm RK Int J Pharm; 2018 Oct; 550(1-2):300-308. PubMed ID: 30153490 [TBL] [Abstract][Full Text] [Related]
6. Partial protection against multiple RT-SHIV162P3 vaginal challenge of rhesus macaques by a silicone elastomer vaginal ring releasing the NNRTI MC1220. Fetherston SM; Geer L; Veazey RS; Goldman L; Murphy DJ; Ketas TJ; Klasse PJ; Blois S; La Colla P; Moore JP; Malcolm RK J Antimicrob Chemother; 2013 Feb; 68(2):394-403. PubMed ID: 23109186 [TBL] [Abstract][Full Text] [Related]
7. Characterization of silicone elastomer vaginal rings containing HIV microbicide TMC120 by Raman spectroscopy. Bell SE; Dennis AC; Fido LA; Malcolm RK; Sirimuthu NM; Toner CF; Woolfson AD J Pharm Pharmacol; 2007 Feb; 59(2):203-7. PubMed ID: 17270074 [TBL] [Abstract][Full Text] [Related]
8. Towards a dapivirine and levonorgestrel multipurpose vaginal ring: Investigations into the reaction between levonorgestrel and addition-cure silicone elastomers. Dallal Bashi YH; McCoy CF; Murphy DJ; Boyd P; Spence P; Kleinbeck K; Devlin B; Malcolm RK Int J Pharm; 2019 Oct; 569():118574. PubMed ID: 31352053 [TBL] [Abstract][Full Text] [Related]
9. Post-use ring weight and residual drug content as potential objective measures of user adherence to a contraceptive progesterone vaginal ring. Murphy DJ; McCoy CF; Plagianos M; RamaRao S; Merkatz R; Clark H; Boyd P; Variano B; Malcolm RK Contraception; 2019 Sep; 100(3):241-246. PubMed ID: 31247194 [TBL] [Abstract][Full Text] [Related]
10. A silicone elastomer vaginal ring for HIV prevention containing two microbicides with different mechanisms of action. Fetherston SM; Boyd P; McCoy CF; McBride MC; Edwards KL; Ampofo S; Malcolm RK Eur J Pharm Sci; 2013 Feb; 48(3):406-15. PubMed ID: 23266465 [TBL] [Abstract][Full Text] [Related]
11. Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings. Malcolm RK; Woolfson AD; Toner CF; Morrow RJ; McCullagh SD J Antimicrob Chemother; 2005 Nov; 56(5):954-6. PubMed ID: 16155060 [TBL] [Abstract][Full Text] [Related]
12. Controlling levonorgestrel binding and release in a multi-purpose prevention technology vaginal ring device. Murphy DJ; Boyd P; McCoy CF; Kumar S; Holt JD; Blanda W; Brimer AN; Malcolm RK J Control Release; 2016 Mar; 226():138-47. PubMed ID: 26878974 [TBL] [Abstract][Full Text] [Related]
13. Safety, Acceptability and Adherence of Dapivirine Vaginal Ring in a Microbicide Clinical Trial Conducted in Multiple Countries in Sub-Saharan Africa. Nel A; Bekker LG; Bukusi E; Hellstrӧm E; Kotze P; Louw C; Martinson F; Masenga G; Montgomery E; Ndaba N; van der Straten A; van Niekerk N; Woodsong C PLoS One; 2016; 11(3):e0147743. PubMed ID: 26963505 [TBL] [Abstract][Full Text] [Related]
14. An interdisciplinary framework for measuring and supporting adherence in HIV prevention trials of ARV-based vaginal rings. MacQueen KM; Tolley EE; Owen DH; Amico KR; Morrow KM; Moench T; Friend DR; Friedland B J Int AIDS Soc; 2014; 17(3 Suppl 2):19158. PubMed ID: 25224617 [TBL] [Abstract][Full Text] [Related]
15. Biomarkers and biometric measures of adherence to use of ARV-based vaginal rings. Stalter RM; Moench TR; MacQueen KM; Tolley EE; Owen DH; J Int AIDS Soc; 2016; 19(1):20746. PubMed ID: 27142091 [TBL] [Abstract][Full Text] [Related]
16. Effect of different insertion regimens on side effects with a combination contraceptive vaginal ring. Weisberg E; Fraser IS; Lacarra M; Mishell DR; Jackanicz T Contraception; 1997 Oct; 56(4):233-9. PubMed ID: 9408704 [TBL] [Abstract][Full Text] [Related]
17. Non-aqueous silicone elastomer gels as a vaginal microbicide delivery system for the HIV-1 entry inhibitor maraviroc. Forbes CJ; Lowry D; Geer L; Veazey RS; Shattock RJ; Klasse PJ; Mitchnick M; Goldman L; Doyle LA; Muldoon BC; Woolfson AD; Moore JP; Malcolm RK J Control Release; 2011 Dec; 156(2):161-9. PubMed ID: 21864598 [TBL] [Abstract][Full Text] [Related]
18. An intravaginal ring for real-time evaluation of adherence to therapy. Moss JA; Baum MM; Easley JT; Cox DM; Smith TJ PLoS One; 2017; 12(4):e0174729. PubMed ID: 28384179 [TBL] [Abstract][Full Text] [Related]
19. Clinical acceptability of an ethylene-vinyl-acetate nonmedicated vaginal ring. Roumen FJ; Dieben TO Contraception; 1999 Jan; 59(1):59-62. PubMed ID: 10342086 [TBL] [Abstract][Full Text] [Related]